-
Top Stock #1:
Quest Diagnostics (DGX)I predicted that Quest Diagnostics (DGX) was poised for another round of great earnings, and I was
right. In the second quarter, DGX reported a 17% profit increase thanks to a jump in clinical testing revenue. As a result, this stock posted a decent
earnings surprise.The laboratory operator earned $188.2 million or $1 per share, compared with $161.3 million or 82 cents per share last year. Revenue increased 3%
to $1.9 billion. Analysts were expecting earnings of 95 cents per share on total sales of $1.89 billion, so Quest easily beat the Street.Thanks to the company’s better-than-expected results, DGX raised its full-year profit outlook for the second time this year, which is great news
for investors. Demand for Quest’s clinical testing services is going strong, so make sure you’re well-positioned in this stock now so you can ride
its upward momentum all the way to top.This company is the leading provider of independent diagnostic testing in the U.S., and has seen very strong sales even amid weak consumer spending.
We have already seen a nearly double-digit return in Quest since our purchase in the June issue of Blue Chip Growth,
and I expect further success for us.
-
Top Stock #2: Sociedad Quimica y Minera (SQM)
Sociedad Quimica y Minera (SQM) is one of my favorite stocks right now and is perfect for just about
any portfolio.A Chile-based producer of specialty fertilizers, iodine and lithium, SQM has tremendous growth potential and is in great shape to profit big-time
from commodity inflation. Prices are rising for commodity fertilizers, and this is translating to higher prices for the company’s specialty plant
nutrients.What’s more, SQM’s lithium and iodine businesses are booming right now and should continue to boost the stock’s bottom line. Lithium is used in
hybrid car batteries and laptops, so once consumer spending firms up this stock should generate even more explosive returns.We’ve already made +20% profits in this stock since adding it our Blue Chip Growth Buy List in March, and
I expect more big things to come.
-
Top Stock #3:
Express Scripts (ESRX)Express Scripts (ESRX) is a North American provider of pharmacy benefit management services. As
this stock’s recent earnings report proves, consumers are still spending a lot of money when it comes to their prescriptions — and ESRX is reaping
the benefits.Last week ESRX reported a profit of $192.3 million, or 88 cents per share — two pennies higher than the consensus — thanks to higher sales of its generic drugs. Revenue for the quarter fell slightly to $5.5 billion from $5.53 billion in the year-ago period, yet still beat estimates of $5.47 billion.
Express Scripts has worked diligently to create savings for its existing customers. This strategy has helped the company to retain clients, improve margins and stay ahead of the competition.Since July 13, the stock is up over 7% for our Blue Chip Growth Buy List and is an excellent buy right now.
-
Top Stock #4:
Apollo Group (APOL)Apollo Group (APOL) is America’s leading private educational provider, mainly through online and
brick-and-mortar classes at its flagship University of Phoenix. With high unemployment in the U.S., more workers are heading back to school for retraining — and
APOL is benefiting from booming sales and class enrollment.The stock reported standout earnings earlier this month, and just as I expected, the stock beat Wall Street’s estimates and posted solid year-over-year
sales growth. The company said earnings soared 44% to $201.1 million or $1.26 per share, compared with $139.1 million or 85 cents per share in the
same quarter a year ago.Wall Street was looking for just $1.12 per share, so APOL beat expectations with a nearly 13% earnings surprise! What’s more,
the education company’s sales rose nearly 26% to top expectations.APOL is clearly at the head of its class. Buy it now!
-
Top Stock #5: AutoZone (AZO)
Did you know that cars are more likely to break down during the summer months because heat creates problems for car batteries, engine cooling systems
and tires? Cars require a lot of extra care during the summer, and AutoZone (AZO) is the go-to place
for vehicle repairs.There’s a reason that AutoZone is on my list of Top 5 Stocks again this month, and that’s because the company continues to enjoy robust business
growth despite the recession.This parts supplier and auto repair company has investors salivating and waiting for a big payout as consumers hang on to their cars longer. I know
I am.NEXT: How Do the Stocks in Your Portfolio Measure Up?
Get Louis Navellier’s latest updates and Buy Below prices on his Top 5 Stocks for August by accepting a six-month, risk-free trial to Blue Chip
Growth. Join at half-price today!
-
How Do the Stocks in Your Portfolio Measure Up?
When it comes to stock analysis or portfolio analysis, Portfolio Grader is an incredibly powerful
tool for individual investors.While a vigorous amount of number-crunching goes on behind the scenes, Portfolio Grader is designed to give you my analysis in easy-to-interpret
A to F letter grades.In Portfolio Grader, the Quantitative Grade you see measures the buying pressure. The Fundamental Grade you see
evaluates the stock’s fundamentals. Blend those two grades together and what you get is the Total Grade. The Total Grade gives you my current buy,
sell or hold recommendation. A=Strong Buy, B=Buy, C=Hold, D=Sell and F=Strong Sell.Here’s a look at how my Top 5 Stocks for August stack up in Portfolio Grader.
In addition to each of the stocks’ grades, you can see my exclusive ratings in the categories of sales growth, earnings growth, cash flow, and six
other key fundamentals, pinpointing the strengths and weaknesses of any given stock.Related Articles:
- 5 Popular Stocks Past Their Prime
- Five Airline Stocks to Sell to Now
- 10 of the Worst Stocks Out There
- Sink Your Teeth Into These Restaurant Stocks
- No-Brainer Bank Stocks You’d Be Crazy NOT to Buy
Put the Power of Portfolio Grader to Work For You Now!
Altogether Portfolio Grader contains some 5,000 stock reports that are updated daily. So, how do the stocks in your portfolio measure up? Click
here!